ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
Clinical trial NCT00440479 · COMPLETED
Trial details
- NCT number
- NCT00440479
- Sponsor
- Janssen-Cilag B.V.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-09-01
- Primary completion
- 2011-01-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.